GRTS Stock Financial Analysis - Gritstone bio, Inc. (NasdaqGS) Stock

Overview

Gritstone bio, Inc., based in the United States, operates primarily in the biotechnology industry, focusing on developing personalized cancer immunotherapies and vaccines. A key player in oncology and infectious disease sectors, the company leverages its proprietary EDGE™ (Epitope Discovery in cancer GEnomes) machine learning platform to identify tumor-specific targets and craft individualized neoantigen immunotherapies. Gritstone Bio is also exploring the infectious disease landscape, as exemplified by its development of a second-generation COVID-19 vaccine, designed to provide broad protection against multiple coronavirus strains. The company's innovative approach aims to substantially advance the effectiveness of treatments for both cancer and infectious diseases, positioning it at the forefront of targeted therapy and vaccine development.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted

Cash Flow: Operations, Investing, Financing

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV

Management Effectiveness

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC

Gross Margins

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin